Bangavax, also known as Bancovid, is a COVID-19 vaccine candidate developed by a Bangladeshi pharmaceutical company Globe Biotech Limited. The vaccine...
10 KB (669 words) - 20:15, 18 July 2024
the Bangladesh government planned to give permission to Bangladeshi-made Bangavax developed by Globe Biotech Ltd. to conduct the first clinical trial that...
53 KB (3,591 words) - 04:01, 20 July 2024
AG0302-COVID‑19 GX-19 Inovio Inactivated KD-414 NDV-HXP-S RNA ARCT-021 ARCT-154 Bangavax CureVac (terminated) HGC019 mRNA-1283 PTX-COVID19-B Sanofi–Translate Bio...
180 KB (23,898 words) - 14:59, 19 August 2024
with different technologies. The company named the mRNA based vaccine as Bangavax, which was initially called Bancovid. Globe Biotech took all the necessary...
140 KB (12,035 words) - 16:33, 9 August 2024
Studies". Inovio Pharmaceutical. 12 May 2021. Retrieved 10 June 2021. "Bangavax Vaccine: Permission sought for clinical trial". The Daily Star. 18 January...
95 KB (18,965 words) - 23:35, 15 September 2024